Delisting riskPopularity #3,749
LUCD · NASDAQ · Medical - Devices

Lucid Diagnostics (LUCD)

Commercializes EsoGuard testing on esophageal cells collected with EsoCheck.

$0.8926
After hours+0.01 (+1.00%)
At close$0.8838(+4.58%)